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Abstract
To investigate the roles of tumor necrosis factor (TNF) and lymphotoxin (LT)-a in the development
and function of the immune system, the Tnf and /.forgeries were simultaneously inactivated in mice
by homologous recombination. These mutant mice are highly susceptible to Listeria
monocytogenes infection and resistant to endotoxic shock induced by the combined
administration of D-galactosamine (D-GaIN) and lipopolysaccharide (LPS). Their splenic
microarchitecture is disorganized, characterized by the loss of the clearly defined marginal zone, ill
defined T and B cell areas, and absence of MAdCAM-1 and reduced ICAM-1, VCAM-1 and Mac-1
expression. They are devoid of peripheral lymph nodes and Peyer's patches, and show a strong
reduction of lgA+ plasma cells in the intestinal lamina propria. The alymphoplasia is accompanied
by a marked B lymphocytosis and reduced basal Ig levels. Ig depositions in the renal glomerulus
and a strong up-regulation of MHC class I antigen expression on endothelial cells of different
tissues are observed. The primary humoral immune response towards sheep red blood cells
reveals a defective IgG isotype switch, while that against vescicular stomatitis virus is normal. The
cytotoxic T cell responses are attenuated, although still effective, against vaccinia, lymphocytic
choriomeningitis virus (LCMV-ARM) and LCMV-WE. In conclusion, the combined inactivation of Tnf
and Lta confirms their essential role in the normal development and function of the immune
system.
Introduction
Tumor necrosis factor (TNF) is a proinflammatory cytokme
involved in host defence and pathogenesis of various diseases
(1,2). Soluble trimenc TNF hgands bind to TNF receptor 1
(TNFR1) and TNFR2, leading to receptor homotrimer formation
(3) and consecutive triggering of various biological responses
such as proliferation, cytotoxicity and apoptosis in target cells.
Lymphotoxin (LT)-a, which like TNF belongs to the growing
family of TNF-like ligands (4), can bind to the same receptors
as TNF. Consequentely, administration of TNF and LT-cc leads
to similar biological responses in vivo and in vitro. In mice,
TNF is mainly expressed in macrophages and T cells, whereas
LT-a expression is confined to T and B cells. The redundancy
in receptor binding and the overlapping expression pattern
of TNF and LT-a renders a clearcut dissection of their function
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rather difficult. Therefore, the importance of both ligands to
TNF receptor-mediated effects tends to be obscured in single
gene knockout mice, because the loss of one ligand may be
compensated by the remaining one. As both genes are very
closely linked on chromosome 17, single mutations cannot
be crossed together. Rather, mice deficient for both ligands
have to be generated by simultaneous targeting of both
genes. Prominent functions of TNF include central roles in
endotoxic shock, host defence and tumor (or parasite)
induced cachexia In addition TNF plays an important, yet
undefined role in the pathogenesis of autoimmune diseases
(5-9). LT-a deficiency has been shown to lead to aberrant
development of the spleen and absence of peripheral lymph
nodes (LN) (10) Recently a third ligand, LT-(J, was cloned
and characterized as present on the cell surface as a LT-a/
2LT-P heterotrimer, able to bind to the newly described LT-(3-
specific receptor (11-13).
To investigate the consequences of the combined defi-
ciency of TNF and LT-a on the immune system we generated
TNF/LT-a double-deficient mice by homologous recombination
in mouse embryonic stem cells (ES) We demonstrate that the
TNF/LT-a double-deficient mice are viable and fertile, but
show profound structural and functional defects of the
immune system
Methods
Reagents
Geneticin (G418) was obtained from Calbiochem (La Jolla,
CA), FIAU [1-(2-deoxy, 2-fluoro-|3-D-arabinofuranosyl)-5-
lodouracil] from Bristol Myers (Squibb Pharmaceutical
Research Institute, Wallingford, CT), D-galactosamine (D-
GalN) from Carl Roth (Karlsruhe, Germany), Concanavalm A
(Con A, C5275) and lipopolysaccharide (LPS; Escherichia
coli, serotype O111B4) from Sigma (St Louis, MO). Biotin-
conjugated isotype-specific goat anti-mouse IgGi, lgG2a,
lgG2b, lgG3, IgM and IgA were from Southern Biotechnology
Associates (Birmingham, AL), and alkaline phosphatase (AP)-
conjugated streptavidin was from Jackson Immunoresearch
(West Grove, PA). IgA-specific goat anti-mouse antibody
(Chemicon IG108, a chain specific), rabbit anti-goat-Cy3
antibody (Jackson) and goat anti-rat-Cy3 antibody (Jackson)
were purchased from Milan Analytica (LaRoche, Switzerland)
Rat anti-mouse MHC class I and class II antibodies were
from ATCC clones M1/42 and M5/114 respectively. The anti
MAdCAM-1 antibody was a generous gift from B. Holzmann
Construction of targeting vector
A 0.8 kb Hinc\\-Dra\ fragment from a TNF genomic clone (14)
(provided by Dr C. V. Jongeneel) was inserted in a clockwise
orientation as the 3' target into the HincW site of a modified
pBLSK+ plasmid lacking sites between C/al and Eag\ A Xho\-
Xba\ fragment carrying the pgk-neo cassette from pPNT (15)
provided by Dr G Veres was inserted into the respective
sites, placing the 3' target beside the neo cassette As a 5'
target, a PCR product (5' primer- 5'-GCGGTACCCAGTCAC-
GACGTTGTAAAAC-3'; 3' primer 5'-GGTCTAGACGGAAGA-
CAGACCTTACCTC-3') encompassing the complete 5' region
of the genomic clone (14) up to bp 1655 was digested with
Asp718l and Xba\ and subcloned into the respective sites,
placing the neo cassette between the genomic 3' and 5'
targets. Subcloning of a EcoRI-/-//ndlll blunt-ended fragment
from pPNT, carrying the thymidine kinase cassette, into the
unique, blunt-ended Asp718l site resulted in the final targeting
construct which was linearized by restriction with Not\.
Generation of TNF/LT-a double-deficient mice
Briefly, 3X107 GS1 ES cells (16) were transfected with 10 ng
linearized targeting vector. Recombinant clones were selected
in media containing G418 and FIAU (17) Mutant ES cell clones
were identified by PCR analysis. Further characterization by
Southern blot analysis revealed a deletion from Lta exon 2 to
the middle of Tnf exon 4 thus completely inactivating both
genes (Fig. 1A). Mutant ES cell clones were injected into
C57BL/6 blastocysts and implantation led in one case to
chimeras and eventual germline transmission of the mutation.
All mice were maintained under specific pathogen-free condi-
tions. Permission for animal experimentation was obtained
from local authorities and performed according to institutional
guidelines All mice used in experiments were 6- to 8-week-
old females.
Genetic analysis of the mutant locus
Genomic DNA was isolated from tail biopsies (18) Digested
DNA (10 u.g) was subjected to agarose gel electropheresis
and subsequently transferred to nylon membranes (Hybond-
N+ , Amersham, Zurich, Switzerland) according to standard
procedures. A genomic probe (Probe A, a Stu\~BamH\ gen-
omic fragment, see Fig. 1A) was random labeled with [a-
32P]dCTP (Amersham) and used for hybridization. Filters were
prehybndized for 15 min at 65°C in 1% BSA, 0.5 M sodium
phosphate, pH 7 2, 20 mM EDTA, 15% deionized formamide
and 7% SDS. Then the denatured probe was added to the
prehybridization mix and hybridization was carried out for
2.5 h. Filters were rinsed twice in 2xSSC, 1% SDS at 65°C,
followed by two 30 min washes at 65°C in 2xSSC, 1%
SDS and 0.2xSSC, 1% SDS respectively, and exposed to
Hyperfilm-MP (Amersham).
LPS/D-GaIN induced shock
Mice (6-8 weeks old) were injected i.p. with a combination
of 20 mg D-GaIN and varying doses of LPS (0.1, 1, 10 or 100
|ig; E. coli, serotype O111:B4) in saline solution (0.9%). The
mice were monitored for hepatic failure and lethality. Blood
was drawn 6 h after treatment from mice anesthetized with
methoxyflurane (Metofane; Pitman-Moore, Mundelein, IL) to
analyze alanine and aspartate aminotransferases using a
COBAS phara kit (F. Hoffmann-LaRoche, Basel, Switzerland)
Mice demonstrating severe signs of endotoxemia were killed
Flow cytometry
Cell suspensions from thymus and spleen were prepared by
gentle squeezing of organ pieces at 4°C in DMEM, 2%
FCS through a wire mesh sieve. Cells were washed and
resuspended in PBS, 2% FCS at 4°C and stained with directly
labeled antibodies. The following antibodies were used: anti-
mouse CD4-phycoerythrin (Becton Dickinson), anti-mouse
CD8-FITC (Becton Dickinson), anti-mouse B220-FITC
(CD45R, clone RA3-6B2; PharMingen, San Diego, CA) and
anti-mouse CD3-biotin (PharMingen). As secondary reagent
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Fig. 1. Inactivation of Tnf and Lta by homologous recombination. (A)
Targeted mutation strategy showing the gene replacement vector
On top, the targeting vector, in the middle the Tnf/Lta locus and the
predicted structure of the mutant locus at the bottom The length of
the wild-type and mutated fragments detectable in the Southern blot
with probe A are given. The position of the diagnostic PCR primers
are indicated by arrows (B) Southern blot analysis of BstEM (B)
digested genomic DNA from tail biopsies of a litter from a
heterozygous intercross showing wild-type, homozygous mutant
and heterozygous pattern of the TNF/LT-o locus (+/+, wild-type,
+/-, heterozygous, -/-, homozygous mutant).
streptavidm-Cy-Chrome (PharMingen) was used. Cells from
peripheral blood were prepared by standard procedures and
labeled as described above. Cells were analyzed with a
FACScan flow cytometer (Becton Dickinson) using Lysys II
software
Analysis of naive Ig levels and induced humoral immune
response
For the determination of isotype levels, Nunc Immuno plates
were coated with 5 ng/ml goat anti-mouse lgG1, lgG2a,
lgG2b, lgG3, IgM and IgA. Bound Ig of diluted serum samples
was detected with AP-coupled isotype-specific goat anti-
mouse Ig antibodies. Serum Ig concentrations were calculated
using mAb of the various isotypes as standards. Mice were
immunized i.p. with sheep red blood cells (SRBC, 108 SRBC
in 0.9% pyrogen free saline), and bled on days 3, 9 and 15
after immunization. Anti-SRBC serum isotype levels were
determined by a sandwich ELISA Maxisorb microtiter plates
(Nunc, Roskilde, Denmark) were coated with 50 u.l of a
solubihzed extract (3 jig/ml) from SRBC prepared according
to Kelly et al. (19) Plates were blocked with PBS/BSA 2% for
2 h at 37°C and incubated overnight with serially diluted
samples. Biotinylated goat anti-mouse Ig isotype was added
for 4 h Subsequently, AP-conjugated streptavidin was added
for 45 min each The reaction was stopped 30 min after
substrate addition with NaOH (1.5 M). Absorbance was read
at 405 nm in a Titerteck Multiskan spectrophotometer (Flow
Laboratories) The titer of a serum sample is expressed as
the reciprocal value of the dilution showing an optical density
of 0.1 over background. Neutralizing IgM and IgG titers
against vesicular stomatitis virus (VSV) were determined at
different time points after i v. infection with 2x106 p f u VSV
(Indiana strain) according to established protocols (20).
Infection with Listeria monocytogenes
Mice were infected i.v with 1.2x103 c f u of L monocytog-
enes Animals were killed after 3 days, and hsterial titers of
spleen and liver were determined by plating serial dilutions
of organ homogenates onto Trypticase-soy agar (21) Lethality
was monitored twice daily in animals infected as described
for the determination of organ titers
In vitro and in vivo anti-viral responses
For the assay of vaccinia virus (VV-WR; WR strain) specific
cytotoxic T lymphocytes (CTL), mice were infected i.v. with
2X106 p f u. and primary ex vivo CTL activity was tested 6
days after infection using MC57 target cells infected with VV-
WR (20). For the lymphocytic choriomeningitis virus (LCMV)-
specific primary CTL response, mice were infected i.v. with
2X103 p f u. LCMV-ARM (Armstrong isolate) or 2X102 p.f.u.
LCMV-WE, and primary ex vivo CTL activity was tested 8
days after infection using MC57 target cells infected with
either LCMV-ARM or LCMV-WE For the LCMV-specific sec-
ondary CTL response, splenocytes from mice infected i.v.
with LCMV-ARM (2X103 p.fu.) or LCMV-WE (2X102 p f u )
were re-stimulated for 5 days in vitro after 8 days with LCMV-
ARM or LCMV-WE infected macrophages and CTL activity
was assessed as described above.
Foot pad swelling and corresponding secondary CTL were
induced by injecting either 3X103 LCMV-ARM or 3X103 p f u.
LCMV-WE into the hind foot pad (i.f.p.). Splenocytes were re-
stimulated in vitro after 23 days for 5 days with LCMV-ARM-
or LCMV-WE-infected macrophages and CTL activity was
assessed as described above.
Histology
Sections were from freshly fixed tissue (buffered 4% formalin
in PBS), paraffin embedded, cut at 5 u.m and stained with
hematoxylin & eosin. Tissues for immunofluorescence analysis
were snap frozen in isopentane, supercooled in liquid nitro-
gen. Primary antibodies were applied overnight at 4°C to
acetone fixed cryosections cut at 5 u.m. After two washes
(PBS, 1% BSA), secondary antibodies were applied for 1
h at room temperature. Slides were mounted in Shandon
Immunomount and tissues were photographed in confocal
mode with a Laser Scan Microscope 320 (Carl Zeiss Micro-
scope Systems, Zurich, Switzerland) utilizing the fluorescence
excitation wavelength of 543 A. Where tissues from positive
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and negative mice are presented together, identical contrast
and brightness settings were employed. Negative controls
(not shown) were uniformly negative
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Fig. 2. (A) Liver transaminase activity in serum and (B) mortality of
mutant and wild-type mice in the LPS/n-Gal sensitization model Data
for liver transammases are presented as mean units/I (± SD) Four
animals were used for the two lower dose of LPS and six animals
were used for the two higher doses of LPS
Results
Combined genetic inactivation of Tnf and Lta
Simultaneous inactivation of 7n/and Lta genes was achieved
in GS1 ES cells (16) with a linearized replacement vector
encompassing essential parts of both genes (Fig. 1A). The
null mutation of both genes was introduced into the mouse
germline by blastocyst injection using established methods.
Targeting of Tnf and Lta loci was verified in the offspring at
the genomic level by Southern blot analysis from tail biopsy
derived DNA (Fig 1B). In contrast to control mice, neither
transcripts nor bioactive TNF could be demonstrated from
LPS and Con A stimulated BMDM and splenocytes respect-
ively (not shown). The generated TNF/LT-a double-deficient
mice represent the first mice devoid of TNF- and LT-a-
dependent signaling. The macroscopic phenotype of TNF/LT-
a double-deficient mice consists of a slightly reduced birth
weight and reduced body weight in adult mice and absence
of LN Homozygous mutant mice are viable and have normal
litter size
Protection from LPS/D-GalN-induced hepatic failure and endo-
toxic shock
TNF has been shown to be a central mediator of endotoxemia
and neutralizing antibodies to TNF could protect mice from
endotoxic shock (22) We therefore assessed our TNF/LT-a
double-deficient mice in the LPS/D-GaIN model While wild-
type mice succumbed to cardiovascular shock and acute
hepatic failure at 1 ng LPS, in the presence of 20 mg D-GaIN,
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Fig. 3. Cytofluorometric analysis of thymus, spleen and blood cells. (A) Thymocytes, (B) T and B lymphocytes in spleen, and (C) peripheral blood
TNF/LT-oc double-deficient mice survived a 100 times higher
dose of LPS (Fig. 2). No toxicity was observed after administra-
tion of D-GaIN alone. These results confirm a key role of TNF
in this endotoxic shock model.
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Abnormalities of secondary lymphatic organs and lympho-
cytosis
It has been shown that administration of TNF antibodies
caused atrophy of thymus and LN (23). We therefore investi-
Fig. 4. Altered microarchitecture in mutant spleen. Hematoxylin & eosin stains of (A) wild-type (X200) and (B) mutant (X100) spleen showing
the absence of a clearly defined marginal zone in the mutant spleen.
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gated whether these alterations also occurred in our TNF/LT-
a-deficient mice. The size and microscopic structure of mutant
thymi, however, were normal. In addition the percentage of
single CD4+, CD8+ and CD4+CD8+ double-positive thymo-
cytes was not altered in mutant mice (Fig 3). On the other
hand, mutant mice were completely devoid of LN and PP.
Microscopic analysis of the tissues at the sites of LN revealed
the presence of lymphatic vessels, but no anlage of lymphoid
organs were detectable (not shown). Hence, the only peri-
pheral lymphoid organ present in mutant mice is the spleen,
which has a normal weight, size and cellularity, but exhibits
a slightly altered lymphocyte composition (Fig 3) and an
altered microarchitecture (Fig. 4). The splenic microarchitec-
ture is characterized by a loss of clearly defined T cell zones
and the absence of MAdCAM-1 expression in the ill-defined
marginal zone (Fig 5). The expression of other adhesion
molecules such as ICAM-1, VCAM-1 and Mac-1 is remarkably
reduced in the marginal zone and red pulp area of mutant
mice (not shown). We further asked whether the leukocyte
counts in peripheral circulation were increased in this context.
The hemogram showed indeed a 4-fold increase of total
leukocyte counts (Table 1). Cytofluorometric analysis revealed
Fig. 5. Immunofluorescent analysis of spleen. Distribution of CD3+ T cells (A) in wild-type and (B) mutant spleen, showing the dissolved T cell
zone in mutant spleen. Distribution of B220+ cells (C) in wild-type and (D) mutant spleen showing the dissolved B cell zone in the mutant
spleen. MAdCAM-1 expression in (E) wild-type and (F) mutant spleen respectively. (A) and (C) as well as (B) and (D) show areas of consecutive
sections (X320).
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Table 1 . Hematology of TNF/LT-a-deficient and control mice
Genotype
(-/-)(+/+)
PLT
(X106)
510±41
484±81
RBC
(X109)
8.35±0.7
8 69±0 2
WBC
(X106)
371+7 1
9.7±2.5
PMN
(%)
4.2±2 1
8.4±5.2
Lympho
(%)
93.8+3.5
88.0±6 5
Monos
(%)
1.2
0.6
Eos
(%)
0.6
3
Values are given as mean±SD (n = 5).
Fig. 6. Decreased incidence of intestinal IgA-specific plasma cells, renal glomerular Ig deposits and aberrant MHC class I expression in
mutant mice. (A) lleum from a wild-type mouse showing intensely lgA+ plasma cells in the lamina propria. The epithelial cells are weakly lgA+
(X450) (B) Duodenum of a mutant mouse with dramatic reduction of lgA+ plasma cells and no fluorescence in the epithelium (X450). (C)
Renal cortex of a wild-type mouse with background lgG2a-specific glomerular deposits (X400). (D) Renal cortex of a mutant mouse showing
increased amount of lgG2a-specific glomerular deposits (X400). (E) MHC class I expression in myocard of wild-type mice is below detection
level. (F) Marked MHC class I up-regulation is apparent in intermyocardial fiber capillary endothelia (X400) in mutant myocard.
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Table 2. Basal isotype levels of TNF/LT-oc-deficient and control mice
Genotype IgM lgG1 lgG2a lgG2b lgG3 IgA
370±46
253+17
144±39
28±5.6
95 ±39
27±5 4
382+114
28+10
66+23
13+2 8
63±13
1 4±0 4
Values are given as mean±SD (n = 5)
65 ± 4% B220+ B cells in mutant mice compared with 44 ±
2% in wild-type mice and a relative decrease of CD3+ T cells
from 45 ± 3% in wild-type to 25 ± 3% in mutant mice (Fig.
3). Considering the absolute lymphocyte counts, mutant mice
have significantly increased peripheral lymphocyte counts
with a 6-fold increase of B cells and a 2-fold increase in T
cells. No evidence of increased B lymphopoiesis could be
found in the bone marrow (data not shown).
PP represent the adequate environment for differentiation
of precursors of lgA+ plasma cells (24) Immunohistochemical
analysis revealed dramatically reduced numbers of lgA+
plasma cells in ileum (Fig 6A and B) and duodenum (not
shown) of the mutants Collectively, TNF/LT-a-deficient mice
show an altered splenic architecture and a complete loss of
other peripheral lymphoid organs with a significant lymph-
ocytosis
Ig deposits in renal mesangium and MHC class I up-regulation
in different organs
Since TNF has been reported to play an important role in
autoimmunity (25), we investigated MHC expression in differ-
ent organs and the kidney for Ig deposits. Immunohistological
analysis of the kidney of 3-month-old mutant mice revealed
granular mesangial Ig deposits (Fig. 6C and D) of the IgM,
lgG1, lgG2a and IgA isotypes in the absence of complement
and any signs of active renal disease. Moreover, TNF/LT-a-
deficient mice show an unexpected distinct up-regulation of
MHC class I expression on capillary endothelial cells in the
myocardium (Fig. 6E and F), lung, thymic medulla and kidney
(not shown) compared with control animals. MHC class II
expression was normal. Despite this alteration in class I
expression and glomerular Ig deposits, TNF/LT-a mice show
no evidence of an autoimmune disorder.
Ig levels and antibody response
We then asked to what extent the basal Ig synthesis and the
humoral immune response was affected in the context of
alymphoplasia, disorganized spleen and B lymphocytosis.
We found a distinct reduction of IgM and all IgG isotypes;
and in accordance with the strong reduction of mucosal IgA
producing plasma cells, very low IgA levels in the serum
(Table 2) The antibody response was measured after immun-
ization with VSV or SRBC. Neutralizing Ig titers against VSV
were determined at different time points, on day 4 for the T-
cell-independent IgM response and on days 8 and 12 for
the strictly T-cell-dependent IgG response. Surprisingly, no
differences between mutant and wild-type neutralizing IgM
and IgG titers against VSV were detectable and the antibody
response correlated with the clearance of VSV (not shown).
However, the SRBC-specific antibody response was markedly
Table 3. SRBC-specific immune response
Day Genotype IgM lgG1
15
8640+1880
32,940±9650
111,780±30,280
35,400±9540
9900±1800
38,700± 10,950
113±22
176±35
3940±1170
232 ±90
66,700±21,890
1425 ±880
Values are given as mean±SEM
altered. Mutant mice were unable to mount a primary IgG
response against SRBC (Table 3, only lgG1 titers are shown)
Thus, despite the observed B cell lymphocytosis, basal Ig
levels are reduced and the response to a T-cell-dependent
antigen is largely abrogated.
Anti-viral activity
TNF has been shown to exert variable effects on anti-viral
activity in wVoand in vitro (26-30). Wild-type and mutant mice
were therefore tested for their CTL responses against VV-WR,
LCMV-ARM and LCMV-WE The primary in vivo CTL response
from mutant mice infected i.v. with VV was slightly reduced
(not shown) but strongly reduced in the case of LCMV-ARM
and LCMV-WE (Fig. 7A and B). Nevertheless, secondary CTL
responses (day 8) against LCMV-ARM and LCMV-WE are
present, although still reduced compared with control mice
(Fig. 7C and D). These CTL present were able to clear the
virus from spleen and liver by day 20 (not shown) If mice
were infected into the foot pad (3000 p f.u.), secondary CTL
were present with LCMV-ARM, but not with LCMV-WE (Fig.
7E and F), demonstrating the lack of LCMV-WE-specific
memory CTL. In addition, footpad swelling was absent after
infection with both viral strains in contrast to control mice
(not shown).
Anti-listerial activity
TNF plays an important role in the defence against intracellular
bacteria such as L monocytogenes and Mycobacterium
bovis (17,31,32). Therefore, mutant and wild-type mice were
infected with low titers of L monocytogenes. In contrast to
wild-type mice, mutant mice could not control this dose of L.
monocytogenes, and eventually die from listeriosis character-
ized by strongly increased titers of L monocytogenes in
liver and spleen (Fig. 8A) and large necrotic lesions with
boundaries of heavily infected hepatocytes (Fig. 8B).
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Fig. 7. Primary and secondary CTL responses against LCMV-ARM
and LCMV-WE Filled symbols represent wild-type data, open symbols
represent data from mutant mice. Each curve represent results from
one mouse. All data points are mean values of duplicate assays.
Primary CTL responses (day 8) after i.v. priming with (A) 2X103
pf.u LCMV-ARM and (B) 2X102 p.f.u LCMV-WE Secondary CTL
responses (day 8) after i v priming with (C) 2x 103 p.f.u LCMV-ARM
and (D) 2x 102 p f.u. LCMV-WE. Secondary CTL responses after i f.p.
injection of (E) 3X103 LCMV-ARM and (F) 3X103 p.fu LCMV-WE
Spontaneous lysis of all used target cells in absence of effector cells
was <15%. Unspecific lysis of unmfected target cells was <20% in
all assays.
Discussion
Simultaneous deletion of the closely linked and homologous
genes coding for TNF and LT-a resulted in viable and fertile
homozygous mutant animals which allowed us to investigate
the specific phenotypic alterations in the immune system
caused by the lack of TNF and LT-a.
Investigations using TNF neutralizing approaches revealed
a central role for TNF as a mediator of endotoxic shock
(22,33-35). Genetic inactivation of TNFR1 (17,31), but not
TNFR2 (36), provides resistance towards LPS-induced endo-
toxic shock after sensitization with D-GalN. The fact that T
cells represent the main source of LT-a in adult mice and that
SCID mice, devoid of T and B cells, are responsive in the
LPS/D-GaIN model of shock (37), precludes an important role
of LT-a in the pathogenesis of LPS-induced endotoxic shock.
Our data, which show complete protection of TNF/LT-a-
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deficient mice from LPS/o-GalN-induced hepatic failure and
endotoxic shock (Fig. 2), confirm the central role of TNF in
this endotoxic shock model.
TNF and LT-a are expressed in the adult thymus (38) and
TNF neutralization during gestation and the first 19 days of
life lead to a marked atrophy of thymus, spleen and LN, and
lymphopenia (23). In vitro, TNF induces thymocyte apoptosis
(39) and either ligand mediates proliferation of immature and
mature T cells in vitro (40). Together, these findings suggest
an important role of TNF and/or LT-a in T cell maturation and
the development of primary and secondary lymphatic organs.
In our TNF/LT-a-deficient mice, however, thymus morphology
as well as thymocyte development was normal, as it was
reported for TNFR1- and TNFR2-deficient mice (31,36). How-
ever, we see alterations of spleen morphology and a complete
absence of LN and PP. As TNFR1- and TNFR2-deficient mice
do not exhibit these abnormalities, signaling through the
newly discovered LT-p" receptor is likely to be responsible for
morphogenesis of LN. LT-a-deficient mice revealed similar
alterations in spleen microarchitecture and absence of LN
(10). Together, this defines the LT-a/LT-f3-receptor interaction
as the cognate ligand-receptor signaling necessary for proper
spleen and LN development. Systemic absence of LN and
PP and presence of ill defined splenic follicles have also been
reported for the a/y mouse (41) These overlapping phenotypic
traits suggest that the aly gene product is involved in the LT-
a/LT-P-receptor signaling pathway.
The distinct lymphocytosis observed in TNF/LT-a-deficient
mice is also found in the LT-a-deficient mice (10), but not in
aly mice (41). Therefore the lack of LN and PP cannot be
invoked as the explanation for this observation, as all three
mutants are devoid of these peripheral lymphatic organs
Adhesion molecules play a critical role in leukocyte emigration
(42), and it has been shown that TNF can induce MAdCAM-
1, ICAM-1 and VCAM-1 (43). The complete absence of splenic
MAdCAM-1 expression combined with the marked reduction
of ICAM-1, VCAM-1 and Mac-1 expression in the marginal
zone and splenic follicles of mutant mice might be responsible
for the reduced margination of lymphocytes and as a con-
sequence for the observed lymphocytosis. The fact that also
ICAM-1 knockout mice present a similar leukocytosis (44)
supports a causal relationship between leukocytosis and
decreased adhesion molecule expression in the TNF/LT-a-
deficient mouse.
A mucosal IgA deficiency was also seen in IL-6-deficient
and in aly mice (41,45) In aly and the TNF/LT-a-deficient
mice, this deficiency is likely due to the absence of PP and
might lead to decreased mucosal immunity as shown in IL-
6-deficient mice (46). The coincidence of IgA deficiency and
glomerular Ig deposits of IgM, IgG and IgA isotypes is
intriguing, since in man, IgA deficiency is associated with the
presence of auto-antibodies, including anti-lgA antibodies
(47). IgA deficiency is the most common form of immuno-
deficiency in man, and its incidence is increased in patients
with allergies, autoimmune and gastrointestinal tract dis-
eases (47).
The aberrant expression of MHC class I molecules on the
endothelial cells of different organs suggests a negative
regulatory function of basal TNF or LT-a levels for MHC class
I expression. TNF has been shown to induce MHC class I
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expression in vitro via an NFicB-like activity (48,-49), and TNF
and LT-a transgenic mice showed increased expression of
MHC class I on islet cells (8). In contrast, TNF induced c-Jun
in 3T3-L1 pre-adipocytes and osteoblastic MC3T3-E1 cells
(50,51), and c-Jun has been shown to inhibit class I expression
in murine L cells (52). These data illustrate the different action
of TNF and/or LT-a on the expression of class I genes which
are mediated, on the one hand, by an NFicB-like activity and,
on the other hand, by the c-Jun/AP-1 transcription factor. A
possible explanation for the aberrant class I expression might
be that the lack of basal TNF or LT-a levels leads to a down-
regulation of c-Jun/AP-1 and to the loss of its negative
regulatory effect on class I transcription resulting in increased
basal class I expression. Whether this aberrant MHC class I
expression is reversible by reintroduction of a TNF or LT-a
transgene and if the aberrant class I expression might promote
mt wt B6 mt wt B6
Fig. 8. (A) Liver and spleen listerial titers of mutant (mt), wild-type (wt) and C57BL/6 (B6) mice 3 days after i.v. infection with 300 c.f.u. of L.
monocytogenes and (B) liver sections of wild-type (top) and mutant mice (bottom) showing extensive necrosis in mutant livers at day 6 after
infection (x90).
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any kind of pathology in a non-specific pathogen-free environ-
ment is currently under investigation Since not only TNF, but
also other cytokmes have been shown to be able to induce
MHC class I expression, serum cytokine levels for IFN-y, IL-
1, IL-12 and transforming growth factor-p were determined,
but no difference in cytokine levels could be demonstrated
in the serum of mutant mice (not shown), which, however,
does not exclude changes in the local production of these
cytokines.
The general reduction of basal Ig levels is likely due to the
absence of LN and PP The reduction in the basal Ig levels
and the defective IgG isotype class switch is reminiscent of
that seen in aly CD40 and CD40L-deficient mice (41,53,54),
and suggests a common defect in all three mutant mice
provoked by different mutations in the same or convergent
signaling pathways of isotype switching. The fact that CD40
ligation has been shown to induce surface LT-a on human B
cells (55) and that TNF/LT-a-deficient mice show an isotype
switch deficiency with the T-cell-dependent antigen SRBC,
strongly suggests a co-stimulatory function of LT-a in T-B cell
interaction necessary for efficient T-cell-dependent isotype
switching
TNF and LT-a can protect against infections with RNA and
DNA viruses (26-29). The anti-viral responses are either
humoral and/or cytotoxic In our experiments we used VSV to
investigate the humoral and VV and LCMV viruses to test the
virus-specific cytotoxic T cell responses. While the antibody
response to SRBC revealed a specific IgG class switch
defect, the neutralizing IgM and IgG response against VSV
was normal in mutant mice The humoral response against a
broad range of viral infection in mice is lgG2a restricted
(56), an isotype response which might be conserved in the
mutant mouse
In contrast to the present neutralizing immune response,
the primary MHC class I restricted ex vivo CTL responses
are strongly reduced for LCMV-ARM and LCMV-WE In compa-
rision, the CTL responses in TNFR1-deficient mice were
normal (17) and no abnormal CTL response was reported for
TNFR2-deficient mice (36). This suggests that signaling via
the LT-p-receptor might be important for the primary ex vivo
CTL responses. It has been shown that TNF is not involved
in the acute (short-term) target cell damage induced by CTL
and a reason for this seems to be the down-regulation of
TNFR1 expression preceding TNF and LT-a secretion in the
effector phase (57,58). The reduction observed in our mutant
mice might stem from the inefficient activation of T^ cells or
precursor CTL due to the absence of a LT-a/LT-p-receptor
mediated co-stimulatory signal or due to low IL-2R expression
of activated precursor CTL. Observations supporting the latter
assumption are the IL-2R a chain induction by TNF and the
suppression of the in vivo priming for TNP-specific CTL by
anti-TNF antibodies (59,60). The interpretation of these in vitro
data is, however, related to the finding that IL-2-deficient mice
exhibit only a marginal reduction of the primary LCMV-specific
CTL response, but clear the virus similar to the TNF/LT-a-
deficient mice (61). The fact that secondary CTL responses
are present, but still reduced compared with control mice, for
both LCMV strains suggests the presence of virus-specific
precursor CTL, which, however, require prolonged activation
to become competent effector cells. Analysis of secondary
CTL 13 and 20 days after i.v. priming resulted in loss of
LCMV-WE-specific CTL from mutant mice, which is probably
the result of virus-specific CTL exhaustion due to fast replica-
tion within the lymphatic and non-lymphatic environment (62).
In any case, mutant mice were still able to clear the viruses
from spleen and liver. Infection of LCMV-ARM as well as
LCMV-WE into the footpad did not provoke footpad swelling,
which reflects the absence of CTL-mediated immunopath-
ology. Nevertheless, footpad injection of LCMV-ARM lead to
a potent secondary CTL response in contrast to LCMV-WE.
The lack of the secondary CTL response towards LCMV-WE
after footpad infection is likely due to CTL exhaustion. The
fact that footpad infection with LCMV-ARM lead to an efficient
secondary CTL response demonstrates that a central
response after a peripheral challenge is possible also in the
absence of LN. We suggest that the lack of footpad swelling,
which is a delayed type hypersensitivity reaction, must be
due to impaired recirculation of memory CTL. This impairment
is likely due to the aberrant splenic microarchitecture and
might therefore be the reason for the absence of peripheral
immunopathology
Infection with the Gram-positive, facultative intracellular
bacterium L monocytogenes has been shown to induce cell-
mediated immunity and efficient clearance of this pathogen
critically depends on proper T cell and macrophage function
(63,64) Genetic inactivation of TCRa, TCRp, MHC class I
and II, IFN-yR, TNFR1 and IL-6 (reviewed in 65) has defined
a critical network of cytokines which play a crucial role in
macrophage activation, extravasation and granuloma forma-
tion. The sensitivity towards low titer infection with L monocy-
togenes seen in the TNF/LT-a-deficient mice is comparable
with that of TNFR1-deficient mice and confirms a crucial role
for TNF in the defence against L monocytogenes infections
The fact that perform (66) and MHC class I deficiency (67)
does not lead to a drastic increase in sensitivity to primary L
monocytogenes infection shows that other cell populations
than T cells, like neutrophils and macrophages (64,68), are
critical for an efficient primary host defence against L. monocy-
togenes. The anti-listerial activity of mutant macrophages
might be impaired at least at two levels. First, the lack of
TNF, which is an important co-stimulator of IL-12 for IFN-y
production by NK cells, might lead to a decreased activation
of macrophages and a reduced development of an efficient
Th1 response (69,70). Second, phagocytosed L. monocytog-
enes might not be killed efficiently. The second assumption
is supported by the fact that IFN-y stimulated BMDM from
mutant mice showed reduced in vitro killing of phagocytosed
L. monocytogenes compared with control macrophages
(not shown).
In conclusion, the combined genetic inactivation of TNF
and LT-a leads to distinct morphological and functional defects
of the peripheral immune system whereby absence of TNF
and LT-a markedly affects innate and acquired immunity,
respectively. The described phenotypic features render these
mice interesting tools to investigate in more detail the roles
of both ligands for the development and function of the
immune system. The interchangability of TNF and LT-a still
leaves open questions, mainly about the functions of the
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soluble form of LT-cc, which might be answered if a TNF
knockout mouse would become available.
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